FAB — Fusion Antibodies Share News
0.000.00%
Last trade - 00:00- £7.57m
- £6.86m
- £2.11m
Fusion Antibodies - Issue of shares to non-executive directors
Fusion Antibodies - AGM statement and trading update
Fusion Antibodies - Notice of AGM
Fusion Antibodies - Director/PDMR Shareholding
RCS - Fusion Antibodies - Investor presentation
Fusion Antibodies - Director/PDMR Shareholding
Fusion Antibodies - Final Results
RCS - Fusion Antibodies - Expansion to OptiMAL collaboration agreement
Fusion Antibodies - Director/PDMR Shareholding
RCS - Fusion Antibodies - Launch of New Interactive Investor Hub
Brief: Fusion Antibodies Says Cash Runway Into Q2 Of Calendar Year 2025
Fusion Antibodies - Trading update
Fusion Antibodies - New contract with existing client
RCS - Fusion Antibodies - Investor presentation
Brief: Fusion Antibodies Initiates Restructuring, Slashing Costs by 38% Including Headcount Reduction
Fusion Antibodies - Year-end trading statement
Fusion Antibodies - Contract to develop a bespoke OptiPhage library
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Holding(s) in Company